NCT05704140

Brief Summary

We will conduct a cross-section analysis regarding patients with catheter-based vascular Access (VA) in Vienna. Collected data will include demographic and clinical information such as age, gender, co-morbidities and imaging data from sonography and computer tomography. Patients of interest will be assessed through a standardized clinician-executed questionnaire aimed at investigating their medical history regarding their VA. Patients will be evaluated for the feasibility of an arteriovenous VA. Patients will receive standard of care ultrasound-based arterial and venous mapping.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 15, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 19, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 30, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

January 30, 2023

Status Verified

January 1, 2023

Enrollment Period

5 months

First QC Date

January 19, 2023

Last Update Submit

January 19, 2023

Conditions

End Stage Renal Failure on Dialysis

Keywords

HaemodialysisDialysis

Outcome Measures

Primary Outcomes (1)

  • Arteriovenous VA

    After a standard-of-care vascular mapping we will note the number of patients receiving catheter based dialysis who would be eligible for arteriovenous dialysis access.

    December 2022-May 2023

Secondary Outcomes (1)

  • Reasons for catheter based dialysis

    December 2022-May 2023

Study Arms (1)

catheter based dialysis

All patients receiving catheter based dialysis in Vienna as of November 2022

Other: Catheter based Dialysis

Interventions

Catheter based DialysisOTHER

We will conduct a cross-section analysis regarding patients with catheter-based VA in Vienna.

catheter based dialysis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients receiving catheter based dialysis in Vienna at the specified timepoint

You may qualify if:

  • Age of 18 and above
  • Catheter-based dialysis as of 01.11.2022

You may not qualify if:

  • Age lower than 18

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Klinik Ottakring

Vienna, 1160, Austria

RECRUITING

Study Officials

  • Markus Plimon, MD

    Klinik Ottakring, Head of Departement of Vascular Surgery

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Markus Plimon, MD

CONTACT

+43 1 49150kor.1ch@gesundheitsverbund.at

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of the vascular access unit

Study Record Dates

First Submitted

January 19, 2023

First Posted

January 30, 2023

Study Start

December 15, 2022

Primary Completion

May 1, 2023

Study Completion

June 1, 2023

Last Updated

January 30, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations

AU(1)